216 related articles for article (PubMed ID: 12771040)
1. Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice.
Fischer SM; Conti CJ; Viner J; Aldaz CM; Lubet RA
Carcinogenesis; 2003 May; 24(5):945-52. PubMed ID: 12771040
[TBL] [Abstract][Full Text] [Related]
2. Difluoromethylornithine is effective as both a preventive and therapeutic agent against the development of UV carcinogenesis in SKH hairless mice.
Fischer SM; Lee M; Lubet RA
Carcinogenesis; 2001 Jan; 22(1):83-8. PubMed ID: 11159745
[TBL] [Abstract][Full Text] [Related]
3. Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition.
Pentland AP; Schoggins JW; Scott GA; Khan KN; Han R
Carcinogenesis; 1999 Oct; 20(10):1939-44. PubMed ID: 10506108
[TBL] [Abstract][Full Text] [Related]
4. Suppression of UV carcinogenesis by difluoromethylornithine in nucleotide excision repair-deficient Xpa knockout mice.
Rebel H; van Steeg H; Beems RB; Schouten R; de Gruijl FR; Terleth C
Cancer Res; 2002 Mar; 62(5):1338-42. PubMed ID: 11888902
[TBL] [Abstract][Full Text] [Related]
5. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis.
Fischer SM; Lo HH; Gordon GB; Seibert K; Kelloff G; Lubet RA; Conti CJ
Mol Carcinog; 1999 Aug; 25(4):231-40. PubMed ID: 10449029
[TBL] [Abstract][Full Text] [Related]
6. Vitamin E analog, alpha-tocopherol ether-linked acetic acid analog, alone and in combination with celecoxib, reduces multiplicity of ultraviolet-induced skin cancers in mice.
Riedel SB; Fischer SM; Sanders BG; Kline K
Anticancer Drugs; 2008 Feb; 19(2):175-81. PubMed ID: 18176114
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapeutic efficacy of topical celecoxib in a murine model of ultraviolet light B-induced skin cancer.
Wilgus TA; Koki AT; Zweifel BS; Rubal PA; Oberyszyn TM
Mol Carcinog; 2003 Sep; 38(1):33-9. PubMed ID: 12949841
[TBL] [Abstract][Full Text] [Related]
8. A definitive role of ornithine decarboxylase in photocarcinogenesis.
Ahmad N; Gilliam AC; Katiyar SK; O'Brien TG; Mukhtar H
Am J Pathol; 2001 Sep; 159(3):885-92. PubMed ID: 11549581
[TBL] [Abstract][Full Text] [Related]
9. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.
Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA
Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ultraviolet light-induced skin carcinogenesis and ornithine decarboxylase activity in sencar and hairless SKH-1 mice fed a constant level of dietary lipid varying in corn and coconut oil.
Berton TR; Fischer SM; Conti CJ; Locniskar MF
Nutr Cancer; 1996; 26(3):353-63. PubMed ID: 8910917
[TBL] [Abstract][Full Text] [Related]
11. Celecoxib, a cyclooxygenase 2 inhibitor as a potential chemopreventive to UV-induced skin cancer: a study in the hairless mouse model.
Orengo IF; Gerguis J; Phillips R; Guevara A; Lewis AT; Black HS
Arch Dermatol; 2002 Jun; 138(6):751-5. PubMed ID: 12056955
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment.
Wilgus TA; Koki AT; Zweifel BS; Kusewitt DF; Rubal PA; Oberyszyn TM
Mol Carcinog; 2003 Oct; 38(2):49-58. PubMed ID: 14502644
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC/Ras transgenic mice.
Lan L; Trempus C; Gilmour SK
Cancer Res; 2000 Oct; 60(20):5696-703. PubMed ID: 11059762
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 inhibitor nimesulide blocks ultraviolet B-induced photocarcinogenesis in SKH-1 hairless mice.
Tang X; Kim AL; Kopelovich L; Bickers DR; Athar M
Photochem Photobiol; 2008; 84(2):522-7. PubMed ID: 18266822
[TBL] [Abstract][Full Text] [Related]
15. Modulation of biologic endpoints by topical difluoromethylornithine (DFMO), in subjects at high-risk for nonmelanoma skin cancer.
Einspahr JG; Nelson MA; Saboda K; Warneke J; Bowden GT; Alberts DS
Clin Cancer Res; 2002 Jan; 8(1):149-55. PubMed ID: 11801552
[TBL] [Abstract][Full Text] [Related]
16. Induction of ornithine decarboxylase activity is a necessary step for mitogen-activated protein kinase kinase-induced skin tumorigenesis.
Feith DJ; Bol DK; Carboni JM; Lynch MJ; Sass-Kuhn S; Shoop PL; Shantz LM
Cancer Res; 2005 Jan; 65(2):572-8. PubMed ID: 15695401
[TBL] [Abstract][Full Text] [Related]
17. Prevention by alpha-difluoromethylornithine of skin carcinogenesis and immunosuppression induced by ultraviolet irradiation.
Gensler HL
J Cancer Res Clin Oncol; 1991; 117(4):345-50. PubMed ID: 2066355
[TBL] [Abstract][Full Text] [Related]
18. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
Liu W; Chen Y; Wang W; Keng P; Finkelstein J; Hu D; Liang L; Guo M; Fenton B; Okunieff P; Ding I
Am J Clin Oncol; 2003 Aug; 26(4):S103-9. PubMed ID: 12902866
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice.
Gupta S; Ahmad N; Marengo SR; MacLennan GT; Greenberg NM; Mukhtar H
Cancer Res; 2000 Sep; 60(18):5125-33. PubMed ID: 11016639
[TBL] [Abstract][Full Text] [Related]
20. Modulation of mouse skin tumor promotion by dietary 13-cis-retinoic acid and alpha-difluoromethylornithine.
Verma AK; Duvick L; Ali M
Carcinogenesis; 1986 Jun; 7(6):1019-23. PubMed ID: 3085964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
